Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biotricity Inc (BTCY)

Biotricity Inc (BTCY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,198
  • Shares Outstanding, K 51,277
  • Annual Sales, $ 3,385 K
  • Annual Income, $ -15,491 K
  • 60-Month Beta 2.40
  • Price/Sales 7.83
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BTCY with:

Options Overview Details

View History
  • Implied Volatility 315.58% ( -209.38%)
  • Historical Volatility 110.39%
  • IV Percentile 94%
  • IV Rank 32.97%
  • IV High 855.61% on 05/09/22
  • IV Low 49.99% on 01/20/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 1,835
  • Open Int (30-Day) 1,836

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.07
  • Low Estimate -0.10
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9745 +26.22%
on 05/12/22
1.9337 -36.39%
on 04/21/22
-0.5700 (-31.67%)
since 04/20/22
3-Month
0.9745 +26.22%
on 05/12/22
3.0950 -60.26%
on 02/25/22
-1.4300 (-53.76%)
since 02/18/22
52-Week
0.9745 +26.22%
on 05/12/22
5.3000 -76.79%
on 12/28/21
-1.6300 (-56.99%)
since 05/20/21

Most Recent Stories

More News
Biotricity Issues Shareholder Update

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

BTCY : 1.2300 (-7.52%)
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022

- Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc. (NASDAQ:BTCY)...

BTCY : 1.2300 (-7.52%)
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022

Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity"...

BTCY : 1.2300 (-7.52%)
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th

- Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared, wireless,...

BTCY : 1.2300 (-7.52%)
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device

- Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity"...

BTCY : 1.2300 (-7.52%)
Biotricity Releases Fiscal 2022 Third Quarter Financial Results

Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End...

BTCY : 1.2300 (-7.52%)
Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022

Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE / February...

BTCY : 1.2300 (-7.52%)
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device

Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022...

BTCY : 1.2300 (-7.52%)
Biotricity Expands Distribution of New Bioheart Device on Amazon.com

New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your Smartphone Now Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle Solution REDWOOD CITY,...

BTCY : 1.2300 (-7.52%)
Biotricity Completes $12 Million Non-Dilutive Debt Financing

Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms 5-year term deal strengthens balance sheet, positions company for multiple...

BTCY : 1.2300 (-7.52%)
SWKH : 19.26 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada....

See More

Key Turning Points

3rd Resistance Point 1.4917
2nd Resistance Point 1.4113
1st Resistance Point 1.3207
Last Price 1.2300
1st Support Level 1.1497
2nd Support Level 1.0693
3rd Support Level 0.9787

See More

52-Week High 5.3000
Fibonacci 61.8% 3.6477
Fibonacci 50% 3.1373
Fibonacci 38.2% 2.6268
Last Price 1.2300
52-Week Low 0.9745

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar